Alvita Pharma Private Limited

Alvita Pharma Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN U24230GJ2010PTC059305 Incorporated 23 January 2010 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company pharma MSME
Revenue · FY 2024
₹119.83 Cr
▲ 7% YoY
Net profit · FY 2024
₹24.12 Cr
Net margin 20.1%
EBITDA · FY 2024
₹33.46 Cr
EBITDA margin 27.9%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹9 Cr
Issued & subscribed
Open charges
₹6 Cr
Satisfied ₹59.65 Cr
Company age
16 yrs
Est. 2010
Employees · EPFO
72
Provident fund records

About Alvita Pharma Private Limited

Data last updated:

Alvita Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 January 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2010PTC059305. Its GSTIN is 24AAICA1744Q2ZD (Gujarat). The company holds 4 GST registrations, of which 3 are active.

The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9 Cr. It is led by directors including Manoj Ramaniklal Vora and Surendra Kumar Lohia.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at B 203 Gopal Palace Near Nehru Nagar Circle Satellite Road Ambavadi, Ahmedabad, Gujarat, India – 380015.

As per the financials filed for FY 2024, the company reported a revenue of ₹119.83 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹24.12 Cr (net margin 20.1%) and EBITDA of ₹33.46 Cr (EBITDA margin 27.9%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 29% over five years.

The company has about 72 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Alvita. As per MCA filings, the company has open charges of ₹6 Cr and satisfied charges of ₹59.65 Cr on record. Court records list 6 cases involving the company, including 4 filed by the company and 2 filed against it; 2 cases are pending. The company has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹9 Lakh; the latest was in January 2024. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is Shine Pharmaceuticals Limited with revenue of ₹120.09 Cr. The company has 8 MSME Form 1 returns on record between 2018 and 2022, listing 275 overdue payments to 47 micro and small suppliers.

Alvita Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0037391). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alvitapharma.co.in.

Company details

CIN U24230GJ2010PTC059305
Registration Number 059305
Incorporation Date 23 January 2010
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-GJ-01-0037391

Recognitions & Rankings of Alvita Pharma

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-GJ-01-0037391

Contact details

Alvita Pharma Private Limited's registered office is in Ahmedabad, Gujarat. Its website is alvitapharma.co.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    B 203 Gopal Palace Near Nehru Nagar Circle Satellite Road Ambavadi, Ahmedabad, Gujarat, India – 380015
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Alvita Pharma Private Limited, buy the company report.

Comprehensive company report
Alvita Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Alvita Pharma operates one associated brand: ALVITA. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical research, development, quality assurance, and global business services by ALVITA.alvitapharma.co.in

Business activity

The main business activity of Alvita Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Alvita Pharma Private Limited, buy the company report.

Financials of Alvita Pharma Private Limited

FY 2024 filings available

Alvita Pharma Private Limited reported revenue of ₹119.83 Cr (up 7% YoY) for FY 2024.

Revenue · FY 2024
₹119.83 Cr ▲ 7%
Net profit · FY 2024
₹24.12 Cr margin 20.1%
EBITDA · FY 2024
₹33.46 Cr margin 27.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 15%
5 years · compounded
▲ 29%
EBITDA CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 26%
5 years · compounded
▲ 33%

Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 7% growth in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹33.46 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹24.12 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin27.9%
Net Profit Margin20.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Alvita Pharma Private Limited, buy the company report.

Board of directors of Alvita Pharma Private Limited

Alvita Pharma has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Manoj Ramaniklal VoraDirector14 Jul 201016 Years 4 MonthsCurrent
Surendra Kumar LohiaDirector02 Feb 201511 Years 9 MonthsCurrent
Sajan Parmeswaran UnnithanDirector16 Sep 201016 Years 2 MonthsCurrent

Peer comparison

Alvita Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Shine Pharmaceuticals Limited₹120.09 Cr (FY 2025)-4.0%Vadodara, Gujarat, India
Ananta Medicare Limited₹120.04 Cr (FY 2025)50.0%Delhi, India
Amol Pharmaceuticals Private Limited₹119.9 Cr (FY 2025)5.0%Jaipur, Rajasthan, India
Alvita Pharma Private Limitedthis company₹119.83 Cr (FY 2024)₹24.12 Cr20.1%7.0%72Ahmedabad, Gujarat, India
M J Biopharm Private Limited₹119.1 Cr (FY 2017)9.0%Mumbai, Maharashtra, India
Pell Tech Health Care Private Limited₹118.72 Cr (FY 2025)16.0%Thane, Maharashtra, India
Ronak Healthcare Private Limited₹118.43 Cr (FY 2025)79.0%Vadodara, Gujarat, India
Zen Pharma Private Limited₹118.25 Cr (FY 2022)24.0%Mumbai, Maharashtra, India

To see the full peer comparison of Alvita Pharma Private Limited, buy the company report.

Auditor

Alvita Pharma Private Limited is audited by Jinesh R. Bhagdev & Co. for the financial year 2022.

Auditor firmFinancial yearFirm registration number
Jinesh R. Bhagdev & Co.FY 2022143988W

Shareholding

The shareholding of Alvita Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Alvita Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹6 Cr
Satisfied charges
₹59.65 Cr
Breakdown by lending institutions
Others₹6.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
03 Jan 201310405597Others₹6 CrOpen
10 Dec 2020100414441Hdfc Bank Limited₹30.51 CrSatisfied
26 Jul 2017100121805Indian Bank₹27.7 CrSatisfied
23 Jan 201510544639Kotak Mahindra Bank Limited₹1.44 CrSatisfied

To see the full charge records of Alvita Pharma Private Limited, buy the company report.

Total charge records: 4 View all charges

Deals & funding

Alvita Pharma Private Limited has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹9 Lakh; the latest was in January 2024.

Total deals
5
Secondary share transfers
4
Funding round
1
Disclosed funding
₹9 Lakh

Deals on record (5 of 5)

WhenDealAmountParties
Jan 2024Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Sep 2020Secondary share transferUndisclosedBuyer: 2 individuals
Seller: an individual
Dec 2012Funding round₹9 LakhInvestors: 2 individuals
Mar 2012Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2011Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

Alvita Pharma Private Limited was last rated by Crisil on 15 Mar 2018.

Rating agencyRated onRating
Crisil15 Mar 2018

To see the full credit ratings and regulatory alerts of Alvita Pharma Private Limited, buy the company report.

MSME payment delays

Alvita Pharma Private Limited has 8 MSME Form 1 returns on record between 2018 and 2022, listing 275 overdue payments to 47 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 47)

SupplierAmount dueDue sinceReported on
an individual supplier
Pavesha Pharma Pack
Zen Scientific Private Limited
an individual supplier
Siddhi Packaging Private Limited

To see the full MSME payment records of Alvita Pharma Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Alvita Pharma Private Limited has a workforce of 72 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
72
Active EPFO establishments
1
Employee growth
35.8%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2772
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Alvita Pharma Private Limited, buy the company report.

GST

Alvita Pharma has 4 GST registrations: 3 active and 1 cancelled or inactive.

Total GSTINs
4
Active
3
Cancelled / inactive
1
GSTINStateStatusRegistered on
24AAICA1744Q2ZDGujaratActive01 Jul 2017
27AAICA1744Q1Z8MaharashtraActive17 Aug 2017
27AAICA1744Q2Z7MaharashtraActive01 Mar 2021

To see the full GST registrations and return filing status of Alvita Pharma Private Limited, buy the company report.

Recent activity

Alvita Pharma Private Limited has 8 board changes on record since 2010: 3 appointments and 5 cessations. The latest: Surendra Kumar Lohia ceased to be Additional Director on 30 Sep 2015.

AGM
Alvita Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Alvita Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
Charges
A charge with Others of Rs. 6.00 Cr registered on 03 Jan 2013 with Charge ID 10405597 was modified on 30 Mar 2024.
Charges
A charge registered on 10 Dec 2020 via Charge ID 100414441 with Hdfc Bank Limited was fully satisfied on 23 May 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 30.51 Cr with Charge ID 100414441 was registered on 10 Dec 2020.
Charges
A charge registered on 26 Jul 2017 via Charge ID 100121805 with Indian Bank was fully satisfied on 17 Jul 2020.
Charges
A charge with Indian Bank amounted to Rs. 27.70 Cr with Charge ID 100121805 was registered on 26 Jul 2017.
Charges
A charge registered on 23 Jan 2015 via Charge ID 10544639 with Kotak Mahindra Bank Limited was fully satisfied on 25 Jul 2017.
Ceased
Surendra Kumar Lohia ceased to be Additional Director.
Appointed
Surendra Kumar Lohia was appointed as Director.
Charges
A charge with Kotak Mahindra Bank Limited amounted to Rs. 1.44 Cr with Charge ID 10544639 was registered on 23 Jan 2015.
Charges
A charge with Others amounted to Rs. 6.00 Cr with Charge ID 10405597 was registered on 03 Jan 2013.

7 earlier events are in the company report.

Frequently asked questions

Alvita Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 January 2010 (16+ years old) and is registered under CIN U24230GJ2010PTC059305.

Alvita Pharma has 3 current directors:

The latest financial statements of Alvita Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Alvita Pharma is 24AAICA1744Q2ZD, registered in Gujarat. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 27AAICA1744Q1Z8 (Maharashtra), 27AAICA1744Q2Z7 (Maharashtra).

The CIN (Corporate Identification Number) of Alvita Pharma is U24230GJ2010PTC059305. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Alvita Pharma has 6 court cases on record: 4 filed by the company and 2 filed against it. 2 are pending.

Alvita Pharma was incorporated on 23 January 2010, making it 16+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Alvita Pharma has 5 deals on record (4 secondary share transfers, 1 funding round), with disclosed funding of ₹9 Lakh; the latest was in January 2024.

The peers of Alvita Pharma by revenue are Shine Pharmaceuticals Limited, Ananta Medicare Limited, Amol Pharmaceuticals Private Limited, M J Biopharm Private Limited, Pell Tech Health Care Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Surendra Kumar Lohia ceased to be Additional Director on 30 Sep 2015. Surendra Kumar Lohia was appointed as Director on 02 Feb 2015. Manoj Ramaniklal Vora ceased to be Additional Director on 18 Jul 2011. Alvita Pharma has 8 board changes on record in total.

Yes, Alvita Pharma is registered as an MSME under Udyam registration (number: UDYAM-GJ-01-0037391).

Alvita Pharma has 8 MSME Form 1 returns on record between 2018 and 2022, listing 275 overdue payments to 47 micro and small suppliers. The latest return was filed on 31 May 2022.